نتایج جستجو برای: intravenous sodium valproate

تعداد نتایج: 264072  

Journal: :British Journal of Clinical Pharmacology 1982

2004
P.N. Suresh Kumar S. Kishore Kumar

A case of Stevens-Johnson syndrome (SJS) following treatment with sodium valproate is presented. A 55-year-old male suffering from manic episode was treated with sodium valproate in addition to haloperidol and trihexiphenidyl. After two weeks he developed cutaneous manifestations of SJS. He was treated with systemic steroids, antihistamines and topical calamine lotion and recovered after a few ...

Journal: :Pharmacological reports : PR 2011
Francisco J Barbosa Bernardete Hesse Rodrigo B de Almeida Irinéia P Baretta Roseli Boerngen-Lacerda Roberto Andreatini

Magnesium sulfate (MgSO4) is used to treat and prevent eclamptic seizures, and several anticonvulsant drugs (e.g., sodium valproate) are clinically effective antimanic drugs. Psychostimulant-induced hyperlocomotion has been proposed as an animal model for the study of antimanic drugs. The present study evaluated the effects of MgSO4 and sodium valproate (as a positive control) on hyperlocomotio...

Journal: :The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1982
D L Keene K Metrakos G V Watters A Sherwin

Sixty-five children with seizure disorders, who had been treated with multiple anticonvulsants but were poorly controlled, were selected from the Montreal Children's Hospital Convulsive Disorder Clinic and Neurology Service and were treated with sodium valproate (valproate). All types of seizure disorders were included in the group. Rapid oral absorption of the drug lead to peak plasma levels i...

2016
Takao Takeshima Norihiro Suzuki Yasuhiko Matsumori Naoki Shimmoto Yuji Kurihara Ryoji Gunji Fumihiko Sakai

BACKGROUND Sodium valproate is a standard drug for first-line prophylactic treatment of migraine. However, little information is available of its use in Japanese patients. AIM To evaluate the effectiveness and safety of an extended-release tablet of sodium valproate in the prophylactic treatment for Japanese patients with migraine by postmarketing surveillance. METHODS This was a prospectiv...

Journal: :Journal of the Medical Association of Thailand = Chotmaihet thangphaet 2007
Pongsakdi Visudhiphan

OBJECTIVE To review the result of the infantile spasms' treatment with sodium valproate followed by nitrazepam or clonazepam. STUDY DESIGN Descriptive retrospective study. SETTING Srinagarind Hospital, Department of Pediatrics, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand. MATERIAL AND METHOD Twenty-four infantile spasms admitted between January 1994 and December 2003 we...

2016
Jamie Bellinge Sanjaya Herath Dharmesh Sonigra

We describe a 29-year-old female who presented with rhabdomyolysis shortly after starting a course of sodium valproate. A thorough investigation revealed a likely mitochondrial origin inducing this susceptibility. An underlying mitochondrial disorder should be considered in all patients who present with undifferentiated disease whilst taking sodium valproate.

Journal: : 2023

Aim: Long-term exposure to sodium valproate, an antiepileptic drug, causes toxic effects in tissues, especially by increasing oxidative stress and inflammation. Rutin is a flavanoid with antioxidant, anti-inflammatory antiapoptotic found naturally many plants. In this study, we aimed investigate the of rutin, natural on valproate-induced spleen tissue damage. 
 Materials Methods: 35 male r...

Journal: :The British journal of psychiatry : the journal of mental science 1987
G G Fisk S M York

As a treatment for tardive dyskinesia, sodium valproate was tested in a double-blind placebo-controlled parallel group trial, with 6-week base-line observation period followed by 6 weeks of treatment. Sodium valproate was not found to be an effective treatment for either tardive dyskinesia or drug-induced Parkinsonism, and did not affect mental state or behaviour.

2018
Mohammad Ali Okhovat Katayoun Ziari Reza Ranjbaran Negin Nikouyan

Alpha-hemoglobin stabilizing protein (AHSP) is a molecular chaperone that can reduce the damage caused by excess free α-globin to erythroid cells in patients with impaired β-globin chain synthesis. We assessed the effect of sodium phenylbutyrate and sodium valproate, two histone deacetylase inhibitors (HDIs) that are being studied for the treatment of hemoglobinopathies, on the expression of AH...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید